The Moderna Laboratory has begun the so-called phase 1 trial stage of an HIV vaccine using messenger RNA technology in the United States, on 56 uninfected adults, both the biotech company and the International AIDS Vaccine Initiative (IAVI) announced Thursday.
Human clinical trials have started for an experimental HIV vaccine that uses the same kind of mRNA technology found in Moderna s successful COVID-19 vaccine, the drug company announced this week.